GlassScriptPhysician profile
Christopher M Ceraldi
NPI 1770661555
$2,596.77
in general payments reported to CMS, 2019-2025
29 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $202 · 2021: $283 · 2022: $155 · 2023: $49.99 · 2024: $450 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $1,257.86 | 2019-2023 | Esophyx |
| Organogenesis INC. | $261.46 | 2024 | Puraply Wound Matrix |
| Smith+Nephew, INC. | $161.57 | 2021-2025 | Grafix Pl |
| Abbvie INC. | $129.53 | 2021-2022 | |
| Abbott Laboratories | $103.36 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Covidien LP | $87.06 | 2019 | |
| Convatec INC. | $71.28 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.38 | 2024-2025 | Hyqvia |
| Eisai INC. | $48.70 | 2024-2025 | |
| Innocoll Pharmaceuticals Limited | $36.47 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $36.38 | 2022-2024 | |
| Solventum Corporation | $35.93 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C. Granufoam |
| Mylan Specialty L.P. | $33.38 | 2020 | |
| Medtronic, INC. | $31.56 | 2021 | |
| Irhythm Technologies, INC. | $23.90 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $21.88 | 2021 | |
| Insulet Corporation | $20.31 | 2019 | |
| Supernus Pharmaceuticals, INC. | $19.19 | 2021 | |
| Access Pro Medical, LLC | $17.76 | 2022 | |
| Polynovo North America LLC | $16.82 | 2024 | Novosorb Btm |
| Amgen INC. | $16.41 | 2021 | |
| Livanova USA, INC. | $16.21 | 2019 | |
| Medtronic Vascular, INC. | $14.29 | 2019 | |
| Hologic Sales and Service, LLC | $13.84 | 2021 | |
| Daiichi Sankyo INC. | $13.26 | 2021 | |
| Acera Surgical, INC. | $12.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.16 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.31 | 2020 | |
| Novo Nordisk INC | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ceraldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.